Molecular Imaging: a Novel Tool To Visualize Pathogenesis of Infections In Situ
暂无分享,去创建一个
Oren Gordon | Camilo A Ruiz-Bedoya | Alvaro A Ordonez | Elizabeth W Tucker | Sanjay K Jain | E. Tucker | A. Ordonez | Sanjay K. Jain | Camilo A. Ruiz-Bedoya | Oren Gordon
[1] M. Bogyo,et al. A Clinical Wide-Field Fluorescence Endoscopic Device for Molecular Imaging Demonstrating Cathepsin Protease Activity in Colon Cancer , 2016, Molecular Imaging and Biology.
[2] V. Havlíček,et al. Early and Non-invasive Diagnosis of Aspergillosis Revealed by Infection Kinetics Monitored in a Rat Model , 2018, Front. Microbiol..
[3] T. van Gelder,et al. Clinical applications of population pharmacokinetic models of antibiotics: Challenges and perspectives , 2018, Pharmacological research.
[4] J. Hoxie,et al. Whole-body immunoPET reveals active SIV dynamics in viremic and antiretroviral therapy–treated macaques , 2015, Nature Methods.
[5] Bruno Jedynak,et al. Noninvasive Pulmonary [18F]-2-Fluoro-Deoxy-d-Glucose Positron Emission Tomography Correlates with Bactericidal Activity of Tuberculosis Drug Treatment , 2009, Antimicrobial Agents and Chemotherapy.
[6] J. Bomanji,et al. Comparison of 99mTc Infecton imaging with radiolabelled white-cell imaging in the evaluation of bacterial infection , 1996, The Lancet.
[7] Ramy A. Fodah,et al. Validation of 2-18F-Fluorodeoxysorbitol as a Potential Radiopharmaceutical for Imaging Bacterial Infection in the Lung , 2018, The Journal of Nuclear Medicine.
[8] G. Lucignani. The many roads to infection imaging , 2007, European Journal of Nuclear Medicine and Molecular Imaging.
[9] W. J. Perry,et al. Integrated molecular imaging reveals tissue heterogeneity driving host-pathogen interactions , 2018, Science Translational Medicine.
[10] D. Hammoud,et al. Molecular imaging of bacterial infections: Overcoming the barriers to clinical translation , 2019, Science Translational Medicine.
[11] M. Javadi,et al. Recent paradigm shifts in molecular cardiac imaging-Establishing precision cardiology through novel 18F-labeled PET radiotracers. , 2019, Trends in cardiovascular medicine.
[12] P. Tonge,et al. Noninvasive Determination of 2-[18F]-Fluoroisonicotinic Acid Hydrazide Pharmacokinetics by Positron Emission Tomography in Mycobacterium tuberculosis-Infected Mice , 2012, Antimicrobial Agents and Chemotherapy.
[13] Dongin Kim,et al. Maltodextrin-based imaging probes detect bacteria in vivo with high sensitivity and specificity. , 2011, Nature materials.
[14] Christopher H Contag,et al. Specific Imaging of Bacterial Infection Using 6″-18F-Fluoromaltotriose: A Second-Generation PET Tracer Targeting the Maltodextrin Transporter in Bacteria , 2017, The Journal of Nuclear Medicine.
[15] M. Pomper,et al. Biodistribution and Radiation Dosimetry of 124I-DPA-713, a PET Radiotracer for Macrophage-Associated Inflammation , 2018, The Journal of Nuclear Medicine.
[16] V. Ivaturi,et al. Noninvasive 11C-rifampin positron emission tomography reveals drug biodistribution in tuberculous meningitis , 2018, Science Translational Medicine.
[17] M. Pomper,et al. Radioiodinated DPA-713 Imaging Correlates with Bactericidal Activity of Tuberculosis Treatments in Mice , 2014, Antimicrobial Agents and Chemotherapy.
[18] P. Tonge,et al. Pharmacokinetic and Pharmacodynamics Relationships , 2017 .
[19] R. Weissleder. Molecular Imaging in Cancer , 2006, Science.
[20] Cathrine A. McKenzie. Antibiotic dosing in critical illness. , 2011, The Journal of antimicrobial chemotherapy.
[21] L. Dodd,et al. Persisting positron emission tomography lesion activity and Mycobacterium tuberculosis mRNA after tuberculosis cure , 2016, Nature Medicine.
[22] H. Yamaguchi,et al. Cerebral metabolic reduction in severe malaria: fluorodeoxyglucose-positron emission tomography imaging in a primate model of severe human malaria with cerebral involvement. , 2004, The American journal of tropical medicine and hygiene.
[23] D. Mollura,et al. Mouse model of pulmonary cavitary tuberculosis and expression of matrix metalloproteinase-9 , 2016, Disease Models & Mechanisms.
[24] Matthew D. Zimmerman,et al. The association between sterilizing activity and drug distribution into tuberculosis lesions , 2015, Nature Medicine.
[25] M. Pomper,et al. Noninvasive molecular imaging of tuberculosis-associated inflammation with radioiodinated DPA-713. , 2013, The Journal of infectious diseases.
[26] L. Dodd,et al. Increased Metabolic Activity on 18F-Fluorodeoxyglucose Positron Emission Tomography–Computed Tomography in Human Immunodeficiency Virus–Associated Immune Reconstitution Inflammatory Syndrome , 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[27] D. Le Guludec,et al. Inability of 99mTc-ciprofloxacin scintigraphy to discriminate between septic and sterile osteoarticular diseases. , 2003, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[28] Jace W. Jones,et al. Sustained virologic control in SIV+ macaques after antiretroviral and alpha(4)beta(7) antibody therapy , 2017 .
[29] A. Lupetti,et al. Detection of fungal infections using radiolabeled antifungal agents. , 2005, Current drug targets.
[30] V. Saini,et al. A Systematic Approach for Developing Bacteria-Specific Imaging Tracers , 2017, The Journal of Nuclear Medicine.
[31] M. Behr,et al. Revisiting the timetable of tuberculosis , 2018, British Medical Journal.
[32] D. Mollura,et al. Molecular Imaging of Influenza and Other Emerging Respiratory Viral Infections , 2011, The Journal of infectious diseases.
[33] I. C. Kok,et al. Molecular Imaging in Cancer Drug Development , 2018, The Journal of Nuclear Medicine.
[34] Jace W. Jones,et al. Sustained virologic control in SIV+ macaques after antiretroviral and α4β7 antibody therapy , 2016, Science.
[35] W. Moses,et al. Total-Body PET: Maximizing Sensitivity to Create New Opportunities for Clinical Research and Patient Care , 2018, The Journal of Nuclear Medicine.
[36] Zibo Li,et al. Infection Imaging With (18)F-FDS and First-in-Human Evaluation. , 2016, Nuclear medicine and biology.
[37] K. Dooley,et al. Determination of [11C]Rifampin Pharmacokinetics within Mycobacterium tuberculosis-Infected Mice by Using Dynamic Positron Emission Tomography Bioimaging , 2015, Antimicrobial Agents and Chemotherapy.
[38] V. Havlíček,et al. Imaging of Pseudomonas aeruginosa infection with Ga-68 labelled pyoverdine for positron emission tomography , 2018, Scientific Reports.
[39] M. Pomper,et al. Imaging Enterobacteriaceae infection in vivo with 18F-fluorodeoxysorbitol positron emission tomography , 2014, Science Translational Medicine.
[40] G. Schoolnik,et al. Corrigendum: Persisting positron emission tomography lesion activity and Mycobacterium tuberculosis mRNA after tuberculosis cure , 2017, Nature Medicine.
[41] M. Daly,et al. Ipr1 gene mediates innate immunity to tuberculosis , 2005, Nature.
[42] M. Ohliger,et al. [11C]Para-Aminobenzoic Acid: A Positron Emission Tomography Tracer Targeting Bacteria-Specific Metabolism. , 2018, ACS infectious diseases.
[43] K. Pienta,et al. Prostate-Specific Membrane Antigen (PSMA)-Targeted PET Imaging of Prostate Cancer: An Update on Important Pitfalls. , 2019, Seminars in nuclear medicine.
[44] Young T. Hong,et al. Hypoxia and tissue destruction in pulmonary TB , 2016, Thorax.
[45] S. Solomon,et al. Antibiotic resistance threats in the United States: stepping back from the brink. , 2014, American family physician.
[46] Robert M. DiFazio,et al. PET CT Identifies Reactivation Risk in Cynomolgus Macaques with Latent M. tuberculosis , 2016, PLoS pathogens.
[47] W. Bishai,et al. Mouse model of necrotic tuberculosis granulomas develops hypoxic lesions. , 2012, The Journal of infectious diseases.
[48] S. Gambhir,et al. Investigation of 6-[18F]-Fluoromaltose as a Novel PET Tracer for Imaging Bacterial Infection , 2014, PloS one.
[49] M. Ohliger,et al. Imaging Active Infection in vivo Using D-Amino Acid Derived PET Radiotracers , 2017, Scientific Reports.
[50] Q. Nguyen,et al. Molecular imaging for cancer diagnosis and surgery. , 2014, Advanced drug delivery reviews.
[51] E. Weinstein,et al. Biodistribution and pharmacokinetics of antimicrobials , 2017 .
[52] G. Borm,et al. Intensified regimen containing rifampicin and moxifloxacin for tuberculous meningitis: an open-label, randomised controlled phase 2 trial. , 2013, The Lancet. Infectious diseases.
[53] A. Lackner,et al. The non‐human primate model of tuberculosis , 2012, Journal of medical primatology.
[54] P. Tonge,et al. Positron Emission Tomography Imaging with 2-[18F]F-p-Aminobenzoic Acid Detects Staphylococcus aureus Infections and Monitors Drug Response , 2018, ACS infectious diseases.
[55] Ralph Weissleder,et al. Molecular imaging of cardiovascular disease. , 2007, Circulation.
[56] P. Price,et al. PET for in vivo pharmacokinetic and pharmacodynamic measurements. , 2002, European journal of cancer.
[57] S. Lapage,et al. Biochemical Tests for Identification of Medical Bacteria , 1976 .
[58] Sanjay K. Jain. The Promise of Molecular Imaging in the Study and Treatment of Infectious Diseases , 2017, Molecular Imaging and Biology.
[59] G. Gensini,et al. Studies on the gaseous content of tuberculous cavities. , 1959, The American review of respiratory disease.
[60] D. Mankoff,et al. Bacterial infection imaging with [18F]fluoropropyl-trimethoprim , 2017, Proceedings of the National Academy of Sciences.
[61] C. Barry,et al. Heterogeneity in tuberculosis pathology, microenvironments and therapeutic responses , 2015, Immunological reviews.
[62] A. van Waarde,et al. [18F]FHPG Positron Emission Tomography for Detection of Herpes Simplex Virus (HSV) in Experimental HSV Encephalitis , 2005, Journal of Virology.
[63] C. Thornton. Development of an Immunochromatographic Lateral-Flow Device for Rapid Serodiagnosis of Invasive Aspergillosis , 2008, Clinical and Vaccine Immunology.
[64] D. Hammoud. Molecular Imaging of Inflammation: Current Status , 2016, The Journal of Nuclear Medicine.
[65] Sanjiv S Gambhir,et al. A molecular imaging primer: modalities, imaging agents, and applications. , 2012, Physiological reviews.
[66] M. Lisanti,et al. Imaging of small-animal models of infectious diseases. , 2013, The American journal of pathology.
[67] F. Jaffer,et al. Metabolic and Molecular Imaging of Atherosclerosis and Venous Thromboembolism , 2017, The Journal of Nuclear Medicine.
[68] Aaron S. Andalman,et al. Structural and molecular interrogation of intact biological systems , 2013, Nature.
[69] M. Levison,et al. Pharmacokinetics and pharmacodynamics of antibacterial agents. , 2009, Infectious disease clinics of North America.
[70] Kyle M. Jones,et al. Differentiating lung cancer and infection based on measurements of extracellular pH with acidoCEST MRI , 2019, Scientific Reports.
[71] L. Younes,et al. Imaging the Evolution of Reactivation Pulmonary Tuberculosis in Mice Using 18F-FDG PET , 2014, The Journal of Nuclear Medicine.
[72] Nicholas A. Be,et al. Bacterial Thymidine Kinase as a Non-Invasive Imaging Reporter for Mycobacterium tuberculosis in Live Animals , 2009, PloS one.
[73] S. Vallabhajosula,et al. Clinically proven radiopharmaceuticals for infection imaging: mechanisms and applications. , 2009, Seminars in nuclear medicine.
[74] T. Vijayan,et al. Using Nuclear Medicine Imaging Wisely in Diagnosing Infectious Diseases , 2017, Open forum infectious diseases.
[75] Mac Faddin,et al. Biochemical tests for identification of medical bacteria , 1976 .
[76] Ophir Vermesh,et al. Toward achieving precision health , 2018, Science Translational Medicine.
[77] Peter Herscovitch,et al. PET/CT imaging correlates with treatment outcome in patients with multidrug-resistant tuberculosis , 2014, Science Translational Medicine.
[78] Winfried Boos,et al. Maltose/Maltodextrin System of Escherichia coli: Transport, Metabolism, and Regulation , 1998, Microbiology and Molecular Biology Reviews.
[79] C. Thornton. Molecular Imaging of Invasive Pulmonary Aspergillosis Using ImmunoPET/MRI: The Future Looks Bright , 2018, Front. Microbiol..
[80] J. Andrews,et al. Determination of minimum inhibitory concentrations. , 2001, The Journal of antimicrobial chemotherapy.
[81] Z. Bhujwalla,et al. Microglia activation in a pediatric rabbit model of tuberculous meningitis , 2016, Disease Models & Mechanisms.
[82] Joel S. Freundlich,et al. Radiosynthesis and PET Bioimaging of 76Br-Bedaquiline in a Murine Model of Tuberculosis. , 2019, ACS infectious diseases.
[83] M. Chase,et al. Digitally Barcoding Mycobacterium tuberculosis Reveals In Vivo Infection Dynamics in the Macaque Model of Tuberculosis , 2017, mBio.
[84] D. Tobin,et al. Adventures within the speckled band: heterogeneity, angiogenesis, and balanced inflammation in the tuberculous granuloma , 2015, Immunological reviews.
[85] E. Fischer,et al. ImmunoPET/MR imaging allows specific detection of Aspergillus fumigatus lung infection in vivo , 2016, Proceedings of the National Academy of Sciences.